209 related articles for article (PubMed ID: 11714112)
41. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
[TBL] [Abstract][Full Text] [Related]
42. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
Melnick S; Cole P; Anderson D; Herbst A
N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
[TBL] [Abstract][Full Text] [Related]
43. Adverse health outcomes in women exposed in utero to diethylstilbestrol.
Hoover RN; Hyer M; Pfeiffer RM; Adam E; Bond B; Cheville AL; Colton T; Hartge P; Hatch EE; Herbst AL; Karlan BY; Kaufman R; Noller KL; Palmer JR; Robboy SJ; Saal RC; Strohsnitter W; Titus-Ernstoff L; Troisi R
N Engl J Med; 2011 Oct; 365(14):1304-14. PubMed ID: 21991952
[TBL] [Abstract][Full Text] [Related]
44. Regression of cervicovaginal abnormalities in DES-exposed women. A comparison of changes in sexually inactive women and the effects of the onset of sexual activity.
Frank AR; Krumholz BA; Deutsch S
J Reprod Med; 1985 May; 30(5):400-3. PubMed ID: 4009562
[TBL] [Abstract][Full Text] [Related]
45. Abnormalities of the genital tract following stilbestrol exposure in utero.
Kurman RJ
Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
[TBL] [Abstract][Full Text] [Related]
46. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol.
Camp EA; Robboy SJ; Hatch EE; Titus-Ernstoff LT; Herbst AL; Strohsnitter W; Kaufman RH; Adam E
J Womens Health (Larchmt); 2012 Feb; 21(2):209-14. PubMed ID: 22150213
[TBL] [Abstract][Full Text] [Related]
47. Invasive squamous cell carcinoma of the vagina in a diethylstilbestrol-exposed woman.
Faber K; Jones M; Tarraza HM
Gynecol Oncol; 1990 Apr; 37(1):125-8. PubMed ID: 2182402
[TBL] [Abstract][Full Text] [Related]
48. Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
Verloop J; van Leeuwen FE; Helmerhorst TJM; de Kok IMCM; van Erp EJM; van Boven HH; Rookus MA
Gynecol Oncol; 2017 Feb; 144(2):305-311. PubMed ID: 27939984
[TBL] [Abstract][Full Text] [Related]
49. Colposcopic findings and intraepithelial neoplasia in diethylstilbestrol-exposed offspring. The Dutch experience.
Helmerhorst TJ; Wijnen HJ; Kenemans P; Tjioe GS; Dijkhuizen HH; Calame JJ; Stolk HG
Am J Obstet Gynecol; 1989 Nov; 161(5):1191-4. PubMed ID: 2589438
[TBL] [Abstract][Full Text] [Related]
50. Cancer risk in men exposed in utero to diethylstilbestrol.
Strohsnitter WC; Noller KL; Hoover RN; Robboy SJ; Palmer JR; Titus-Ernstoff L; Kaufman RH; Adam E; Herbst AL; Hatch EE
J Natl Cancer Inst; 2001 Apr; 93(7):545-51. PubMed ID: 11287449
[TBL] [Abstract][Full Text] [Related]
51. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
[TBL] [Abstract][Full Text] [Related]
52. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
Herbst AL; Scully RE; Robboy SJ
J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
[TBL] [Abstract][Full Text] [Related]
53. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
Newbold RR; McLachlan JA
Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
[TBL] [Abstract][Full Text] [Related]
54. Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guidelines.
Tedeschi CA; Rubin M; Krumholz BA
J Low Genit Tract Dis; 2005 Jan; 9(1):11-8. PubMed ID: 15870516
[TBL] [Abstract][Full Text] [Related]
55. Preeclampsia risk in women exposed in utero to diethylstilbestrol.
Troisi R; Titus-Ernstoff L; Hyer M; Hatch EE; Robboy SJ; Strohsnitter W; Palmer JR; Øglaend B; Adam E; Kaufman R; Herbst AL; Hoover RN
Obstet Gynecol; 2007 Jul; 110(1):113-20. PubMed ID: 17601905
[TBL] [Abstract][Full Text] [Related]
56. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
Piver MS; Lele SB; Baker TR; Sandecki A
Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
[TBL] [Abstract][Full Text] [Related]
57. An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract.
Troisi R; Bertrand K; Hatch EE; Strohsnitter WC; Aagaard K; Robboy SJ; Gierach G; Titus L
Obstet Gynecol; 2024 Apr; 143(4):603-606. PubMed ID: 38422500
[TBL] [Abstract][Full Text] [Related]
58. Diethylstilbestrol in pregnancy: an update.
Kinch RA
Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
[TBL] [Abstract][Full Text] [Related]
59. Screening for cancers of the cervix and vagina for women exposed to diethylstilbestrol (DES) in utero.
Tournaire M; Devouche E; Lafaye N; Levadou A
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102042. PubMed ID: 33310134
[TBL] [Abstract][Full Text] [Related]
60. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Norusis MJ; Welch WR; Scully RE
Am J Obstet Gynecol; 1979 Dec; 135(7):876-86. PubMed ID: 507130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
